Craft

Tandem Diabetes Care

Stock Price

$32.9

2024-10-29

Market Capitalization

$2.2 B

2024-10-29

Revenue

$940.2 M

FY, 2024

Tandem Diabetes Care Summary

Company Summary

Overview
Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. It is primarily focused on manufacturing, sales, and support of its flagship pump platform t:slim X2. In addition, the company sells disposable products including insulin cartridges, infusion sets, belt clips, and cases for use with pumps. Tandem Diabetes Care also offers t:connect, a data management application to display diabetes therapy management data, integrated CGMs, and supported blood glucose meters.
Type
Public
Status
Active
Founded
2006
HQ
San Diego, CA, US | view all locations
Website
https://www.tandemdiabetes.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • John Sheridan

    John Sheridan, President and Chief Executive Officer, Director

  • Leigh Vosseller

    Leigh Vosseller, Executive Vice President, Chief Financial Officer and Treasurer

  • David Berger

    David Berger, Executive Vice President and Chief Operating Officer

  • Brian Hansen

    Brian Hansen, Executive Vice President and Chief Commercial Officer

Operating MetricsView all

Facilities Leased (US), square feet

417K
13.6%

FY, 2022

Pumps Shipped to Date

420K
27.3%

FY, 2022

Products

3

FY, 2022

LocationsView all

3 locations detected

  • San Diego, CA HQ

    United States

    12400 High Bluff Dr

  • Markham, ON

    Canada

    675 Cochrane Dr Tower – 6th Floor

  • Schiphol, NH

    Netherlands

    Schiphol Boulevard 359

Tandem Diabetes Care Financials

Summary Financials

Revenue (FY, 2024)
$940.2M
Gross profit (FY, 2024)
$489.6M
Net income (FY, 2024)
($96.0M)
Cash (FY, 2024)
$69.2M
EBIT (FY, 2024)
($99.1M)
Enterprise value
$2.4B

Footer menu